Lucid Diagnostics Inc. LUCD
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -18.39% | 17.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.39% | 17.36% | |||
| Cost of Revenue | -2.84% | -11.08% | |||
| Gross Profit | -793.10% | 107.86% | |||
| SG&A Expenses | -6.46% | 10.53% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.58% | 6.77% | |||
| Operating Income | 4.10% | -5.67% | |||
| Income Before Tax | 42.87% | 15.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 42.87% | 15.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.87% | 15.98% | |||
| EBIT | 4.10% | -5.67% | |||
| EBITDA | 4.18% | -5.76% | |||
| EPS Basic | 56.47% | 52.34% | |||
| Normalized Basic EPS | 7.83% | 19.33% | |||
| EPS Diluted | 56.47% | 52.34% | |||
| Normalized Diluted EPS | 7.83% | 19.33% | |||
| Average Basic Shares Outstanding | 4.27% | 30.71% | |||
| Average Diluted Shares Outstanding | 4.27% | 30.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||